
Sign up to save your podcasts
Or


Professor Luke O’Neill dives into the science behind Type-1 Diabetes for this week's podcast, answering a question from listener Sarah. Luke explains the key differences between Type-1 and other forms of diabetes, guiding us through the early symptoms—intense thirst, frequent urination, unexplained weight loss, fatigue, vision issues, and nausea—and highlighting the serious long-term complications, from kidney damage to blindness and ulcers.
Luke also breaks down how Type-1 Diabetes isn’t purely genetic, exploring the role of psychological stress alongside hereditary factors. He takes listeners through the latest treatments, from insulin therapy and lifestyle adjustments to cutting-edge innovations like insulin pumps and artificial pancreases.
The discussion moves into the exciting frontiers of research, including stem cell treatments targeting the pancreas, and Luke’s optimism that breakthroughs in Type-1 Diabetes could pave the way for tackling other autoimmune conditions. For anyone living with or curious about the disease, Luke’s insight offers both clarity and hope.
Listeners can request future topics by emailing [email protected].
By Newstalk5
55 ratings
Professor Luke O’Neill dives into the science behind Type-1 Diabetes for this week's podcast, answering a question from listener Sarah. Luke explains the key differences between Type-1 and other forms of diabetes, guiding us through the early symptoms—intense thirst, frequent urination, unexplained weight loss, fatigue, vision issues, and nausea—and highlighting the serious long-term complications, from kidney damage to blindness and ulcers.
Luke also breaks down how Type-1 Diabetes isn’t purely genetic, exploring the role of psychological stress alongside hereditary factors. He takes listeners through the latest treatments, from insulin therapy and lifestyle adjustments to cutting-edge innovations like insulin pumps and artificial pancreases.
The discussion moves into the exciting frontiers of research, including stem cell treatments targeting the pancreas, and Luke’s optimism that breakthroughs in Type-1 Diabetes could pave the way for tackling other autoimmune conditions. For anyone living with or curious about the disease, Luke’s insight offers both clarity and hope.
Listeners can request future topics by emailing [email protected].

177 Listeners

6 Listeners

7 Listeners

2 Listeners

54 Listeners

60 Listeners

61 Listeners

57 Listeners

2 Listeners

5 Listeners

13 Listeners

42 Listeners

2 Listeners

3 Listeners

0 Listeners

5 Listeners

1 Listeners

2 Listeners

0 Listeners

362 Listeners

89 Listeners

37 Listeners

23 Listeners

51 Listeners

109 Listeners

37 Listeners

41 Listeners

23 Listeners

1 Listeners

1 Listeners

9 Listeners

10 Listeners

0 Listeners

3 Listeners